See more : Local Corporation (LOCM) Income Statement Analysis – Financial Results
Complete financial analysis of Shunten International (Holdings) Limited (0932.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shunten International (Holdings) Limited, a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- Borussia Dortmund GmbH & Co. Kommanditgesellschaft auf Aktien (BVB.DE) Income Statement Analysis – Financial Results
- Condor Gold Plc (CNR.L) Income Statement Analysis – Financial Results
- Pacific Assets Trust plc (PAC.L) Income Statement Analysis – Financial Results
- Avantax, Inc. (AVTA) Income Statement Analysis – Financial Results
- Integral Acquisition Corporation 1 (INTEU) Income Statement Analysis – Financial Results
Shunten International (Holdings) Limited (0932.HK)
About Shunten International (Holdings) Limited
Shunten International (Holdings) Limited, an investment holding company, engages in marketing, sale, and distribution of health and beauty supplements and products in Hong Kong, Taiwan, and internationally. The company provides its products under its proprietary brands and private label brands. It is also involved in property investment, license and trademark holding, e-commerce promotion, Chinese medical consultation, and health food processing businesses. In addition, it sells and distributes healthcare products; trades in health supplements; and provides general administrative services. The company was formerly known as RM Group Holdings Limited and changed its name to Shunten International (Holdings) Limited in February 2018. Shunten International (Holdings) Limited was founded in 2002 and is headquartered in Kwai Chung, Hong Kong.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 235.59M | 216.13M | 162.99M | 223.15M | 318.13M | 393.49M | 264.45M | 220.85M | 189.96M | 227.68M | 169.68M | 163.77M |
| Cost of Revenue | 51.37M | 49.82M | 50.45M | 61.70M | 82.42M | 137.88M | 83.30M | 63.73M | 42.96M | 50.81M | 39.69M | 34.76M |
| Gross Profit | 184.21M | 166.31M | 112.55M | 161.45M | 235.71M | 255.61M | 181.15M | 157.12M | 147.00M | 176.87M | 129.99M | 129.01M |
| Gross Profit Ratio | 78.19% | 76.95% | 69.05% | 72.35% | 74.09% | 64.96% | 68.50% | 71.14% | 77.39% | 77.69% | 76.61% | 78.78% |
| Research & Development | 0.00 | 0.00 | 1.58M | 3.66M | 3.96M | 4.54M | 3.40M | 3.07M | 2.13M | 3.15M | 2.02M | 2.07M |
| General & Administrative | 103.80M | 85.26M | 86.53M | 121.82M | 189.73M | 220.04M | 168.86M | 97.04M | 91.63M | 81.17M | 76.35M | 45.74M |
| Selling & Marketing | 54.50M | 47.45M | 29.87M | 39.50M | 63.84M | 67.55M | 49.57M | 43.87M | 40.29M | 55.14M | 48.44M | 38.02M |
| SG&A | 158.50M | 132.70M | 116.39M | 161.32M | 253.57M | 287.59M | 218.43M | 140.91M | 131.93M | 136.31M | 124.79M | 83.75M |
| Other Expenses | 13.36M | 15.84M | 26.19M | -2.46M | 26.49M | 11.58M | 660.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 171.86M | 132.70M | 115.43M | 148.23M | 260.67M | 324.60M | 247.72M | 140.70M | 131.01M | 136.98M | 129.71M | 82.42M |
| Cost & Expenses | 223.24M | 182.52M | 165.88M | 209.93M | 343.09M | 462.47M | 331.02M | 204.44M | 173.96M | 187.79M | 169.40M | 117.17M |
| Interest Income | 57.00K | 217.00K | 9.00K | 9.40M | 8.00K | 20.00K | 21.00K | 43.00K | 106.00K | 258.00K | 264.00K | 0.00 |
| Interest Expense | 7.78M | 4.97M | 12.88M | 15.18M | 37.22M | 20.97M | 8.57M | 776.00K | 545.00K | 301.00K | 104.00K | 110.00K |
| Depreciation & Amortization | 9.12M | 6.51M | 7.50M | 12.86M | 14.99M | 15.17M | 13.05M | 4.78M | 3.15M | 2.30M | 1.78M | 1.47M |
| EBITDA | 21.47M | 55.24M | -18.47M | -76.60M | 44.90M | 34.97M | -120.43M | 21.19M | 18.43M | 42.52M | 2.34M | 48.06M |
| EBITDA Ratio | 9.11% | 22.88% | 19.05% | -3.22% | -5.25% | -9.45% | -20.13% | 9.70% | 10.23% | 18.68% | 1.38% | 29.35% |
| Operating Income | 12.35M | 48.73M | -28.76M | -101.15M | -18.26M | 20.48M | -133.48M | 16.42M | 15.28M | 40.22M | 551.00K | 46.59M |
| Operating Income Ratio | 5.24% | 22.55% | -17.65% | -45.33% | -5.74% | 5.20% | -50.48% | 7.43% | 8.04% | 17.66% | 0.32% | 28.45% |
| Total Other Income/Expenses | -7.78M | -4.97M | -13.23M | -15.18M | 10.98M | -20.97M | -8.57M | -776.00K | -545.00K | -301.00K | -104.00K | 231.00K |
| Income Before Tax | 4.57M | 43.77M | -41.64M | -116.33M | -55.48M | -493.00K | -142.06M | 15.64M | 14.74M | 39.92M | 447.00K | 46.48M |
| Income Before Tax Ratio | 1.94% | 20.25% | -25.55% | -52.13% | -17.44% | -0.13% | -53.72% | 7.08% | 7.76% | 17.53% | 0.26% | 28.38% |
| Income Tax Expense | 4.06M | 2.59M | 2.74M | 7.77M | 1.51M | 10.22M | 2.69M | 3.82M | 4.31M | 8.39M | 6.18M | 7.22M |
| Net Income | 571.00K | 41.04M | -43.89M | -127.38M | -139.69M | -4.34M | -139.22M | 12.75M | 10.42M | 31.52M | -5.73M | 39.26M |
| Net Income Ratio | 0.24% | 18.99% | -26.93% | -57.08% | -43.91% | -1.10% | -52.64% | 5.77% | 5.49% | 13.84% | -3.38% | 23.98% |
| EPS | 0.00 | 0.01 | -0.02 | -0.05 | -0.06 | 0.00 | -0.07 | 0.01 | 0.01 | 0.02 | 0.00 | 0.03 |
| EPS Diluted | 0.00 | 0.01 | -0.02 | -0.05 | -0.06 | 0.00 | -0.07 | 0.01 | 0.01 | 0.02 | 0.00 | 0.03 |
| Weighted Avg Shares Out | 3.12B | 3.11B | 2.88B | 2.56B | 2.36B | 2.12B | 2.11B | 2.08B | 2.07B | 2.06B | 1.79B | 1.54B |
| Weighted Avg Shares Out (Dil) | 3.11B | 3.11B | 2.88B | 2.56B | 2.36B | 2.12B | 2.11B | 2.08B | 2.07B | 2.06B | 1.79B | 1.54B |
Source: https://incomestatements.info
Category: Stock Reports